Hypercoagulable States
Conditions
Brief summary
Retrospective, cohort study chart review in patients with hypercoagulable states.
Detailed description
* Retrospective, cohort study chart review in patients at Methodist Health System * Data will be pulled on all patients with hypercoagulable states identified by ICD-9/ICD-10 codes from January 1st, 2015 to December 31st, 2019
Interventions
OTHERObservational
Retrospective chart review
Sponsors
Methodist Health System
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients ≥ 18 year-old * Patients with diagnosis of hypercoagulable state identified by ICD-9/ICD-10 codes * Patients who were prescribed DOACs or VKA for primary or secondary prevention of thrombosis
Exclusion criteria
* Patients with FDA-approved indications of oral anticoagulants including atrial fibrillation or treatment/prevention of thrombotic events unrelated to specified hypercoagulable states * Patients with incomplete electronic medical records
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rates of thrombotic events during the study period | Jan 1,2015 - Dec 31st, 2019 | Rates of thrombotic events during the study period |
| Rates of hemorrhagic events during the study period | Jan 1,2015 - Dec 31st, 2019 | Rates of hemorrhagic events during the study period |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rates of DOAC prescribing for thrombosis prevention in hypercoagulable states | Jan 1,2015 - Dec 31st, 2019 | Rates of DOAC prescribing for thrombosis prevention in hypercoagulable states |
Countries
United States
Outcome results
None listed